MARKET

HROW

HROW

Harrow Health Inc
NASDAQ
11.71
-0.11
-0.93%
Opening 12:39 04/18 EDT
OPEN
11.75
PREV CLOSE
11.82
HIGH
11.87
LOW
11.42
VOLUME
120.56K
TURNOVER
0
52 WEEK HIGH
28.25
52 WEEK LOW
7.60
MARKET CAP
414.10M
P/E (TTM)
-15.6467
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at HROW last week (0408-0412)?
Weekly Report · 3d ago
HROW, HCAT and EGRX are among after hour movers
On the Move HROW, HCAT and EGRX are among after hour movers. Eagle Pharmaceuticals (EGRX) is down 10%. Applied Optoelectronics (AAOI) and Harrow (HROW) are among the gainers.
Seeking Alpha · 5d ago
Harrow Health Price Target Announced at $24.00/Share by Craig-Hallum
Dow Jones · 6d ago
Harrow Health Initiated at Buy by Craig-Hallum
Dow Jones · 6d ago
Craig-Hallum Initiates Coverage On Harrow with Buy Rating, Announces Price Target of $24
Benzinga · 04/11 16:32
HARROW, INC. <HROW.O> : CRAIG-HALLUM INITIATES COVERAGE WITH BUY RATING AND TARGET PRICE $24
Reuters · 04/11 11:17
U.S. RESEARCH ROUNDUP-Airbnb, Albemarle, Biogen
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Airbnb, Albemarle and Biogen among those with revised targets. AIG, Aflac and Allstate among companies with new targets for the day. Analysts cut target prices on some of the companies.
Reuters · 04/11 07:32
Weekly Report: what happened at HROW last week (0401-0405)?
Weekly Report · 04/08 12:01
More
About HROW
Harrow, Inc. is an eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.

Webull offers Harrow Inc stock information, including NASDAQ: HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HROW stock methods without spending real money on the virtual paper trading platform.